ADMA - ADMA BIOLOGICS, INC.


16.54
0.160   0.967%

Share volume: 8,245,421
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$16.38
0.16
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 11-07-2024 03-18-2025 05-07-2025 08-06-2025 11-05-2025 02-25-2026
Total revenue 81.875 M 107.191 M 119.839 M 117.549 M 114.802 M 121.984 M 134.224 M 139.163 M
Cost of revenue 42.767 M 49.738 M 60.180 M 54.216 M 53.705 M 54.757 M 58.598 M 50.348 M
Gross profit 39.108 M 57.453 M 59.659 M 63.333 M 61.097 M 67.227 M 75.626 M 88.815 M
    46.91% 3.84% 6.16% -3.53% 10.03% 12.49% 17.44%  
Operating expenses 17.094 M 18.110 M 19.993 M 24.985 M 26.191 M 24.397 M 24.576 M 26.014 M
Selling general and admin 16.644 M 17.550 M 19.581 M 24.594 M 25.365 M 23.366 M 23.048 M 24.637 M
Research and development 450.000 K 560.000 K 412.000 K 391.000 K 826.000 K 1.031 M 1.528 M 1.377 M
Total expenses 17.287 M 18.252 M 20.021 M 25.010 M 26.216 M 24.429 M 24.614 M 26.063 M
    5.58% 9.69% 24.92% 4.82% -6.82% 0.76% 5.89%  
Operating income 21.821 M 39.201 M 39.638 M 38.323 M 34.881 M 42.798 M 51.012 M 62.752 M
Ebit 21.786 M 39.185 M 39.582 M 38.237 M 34.817 M 42.690 M 50.991 M 62.733 M
Pretax income 18.401 M 35.851 M 36.749 M 34.713 M 33.450 M 40.097 M 47.515 M 61.594 M
    94.83% 2.50% -5.54% -3.64% 19.87% 18.50% 29.63%  
Income tax 595.000 K 3.789 M 840.000 K -77.183 M 6.546 M 5.878 M 11.087 M 12.215 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 17.806 M 32.062 M 35.909 M 111.896 M 26.904 M 34.219 M 36.428 M 49.379 M
    80.06% 12.00% 211.61% -75.96% 27.19% 6.46% 35.55%